Lenalidomide as potential treatment in small cell neuroendocrine lung cancer with del 5q
Open Access
- 11 July 2018
- journal article
- Published by Peertechz Publications Private Limited in Scientific Journal of Genetics and Gene Therapy
- p. 002-003
- https://doi.org/10.17352/sjggt.000014
Abstract
No abstract availableThis publication has 10 references indexed in Scilit:
- Coexisting multiple myeloma, lymphoma, and non-small cell lung cancer: a case report and review of the literatureInternational Medical Case Reports Journal, 2017
- Lenalidomide induces apoptosis and alters gene expression in non-small cell lung cancer cellsOncology Letters, 2012
- Del(5q) Is Associated With Clinical and Histological Parameters in Small Cell Neuroendocrine Lung CarcinomaInternational Journal of Surgical Pathology, 2008
- Thalidomide and lenalidomide: Mechanism-based potential drug combinationsLeukemia & Lymphoma, 2008
- Genomic Aberrations and Survival in Chronic Lymphocytic LeukemiaThe New England Journal of Medicine, 2000
- Alterations of Chromosome Arms 1p and 19q as Predictors of Survival in Oligodendrogliomas, Astrocytomas, and Mixed OligoastrocytomasJournal of Clinical Oncology, 2000
- Genetic changes in the spectrum of neuroendocrine lung tumorsCancer, 1999
- The Importance of Diagnostic Cytogenetics on Outcome in AML: Analysis of 1,612 Patients Entered Into the MRC AML 10 TrialBlood, 1998
- Primary small-cell lung carcinomas and their metastases are characterized by a recurrent pattern of genetic alterationsInternational Journal of Cancer, 1997
- Detailed deletion mapping of the short arm of chromosome 3 in small cell and non-small cell carcinoma of the lungLung Cancer, 1994